ESMO 2021: Cabozantinib for collecting duct carcinoma – the BONSAI study
Metastatic collecting duct carcinoma is an aggressive form of RCC, [...]
Metastatic collecting duct carcinoma is an aggressive form of RCC, [...]
Ipilimumab plus nivolumab is a standard first-line treatment for patients [...]
There is increasing interest in using treatment breaks to reduce [...]
Following expert clinical advice, the government is ending the requirement [...]
NHS England is about to start a large-scale trial of [...]
The Association of the British Pharmaceutical Industry (ABPI) have formed [...]
Stereotactic radiotherapy is a very precise method of radiotherapy that [...]
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive form of [...]
An ongoing phase 2 study of a combination of two [...]
Surgeons use three-dimensional (3D) models to improve their understanding of [...]